8 terminated. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Terminated 8 |
Follow Phosphorus Metabolism Disorders: new trials by email Literature Review of Phosphorus Metabolism Disorders trials Research Report on Phosphorus Metabolism Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia PA21 (Velphoro®), Calcium Acetate (Phoslyra®) - Hyperphosphatemia | Phase 3 | Terminated | Vifor Fresenius Medical Care Renal Pharma | 85 | 2016-05-26 | 2019-09-10 |
| Dose-finding Study of MCI-196 colestilan-L, colestilan-M, colestilan-H - Chronic Kidney Disease, Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 10 | 2014-04-01 | 2015-05-27 |
| Long-term Extension Study of MCI-196 colestilan, CBPB - Chronic Kidney Disease, Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 6 | 2013-08-01 | 2015-05-27 |
| Safety and Tolerability Study of MCI-196 colestilan - Chronic Kidney Disease, Not on Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 4 | 2013-08-01 | 2015-05-27 |
| Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate Magnesium iron hydroxycarbonate, Lanthanum carbonate, Placebo - Chronic Kidney Failure | Phase 3 | Terminated | Ineos Healthcare Limited | 657 | 2009-07-01 | 2010-10-19 |
| Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride Fermagate, Sevelamer hydrochloride - Chronic Kidney Failure | Phase 3 | Terminated | Ineos Healthcare Limited | 1000 | 2009-07-01 | 2010-10-19 |
| A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis Sevelamer carbonate, Placebo for sevelamer carbonate - Chronic Kidney Disease, Hyperphosphatemia | Phase 3 | Terminated | Genzyme, a Sanofi Company | 5 | 2009-01-01 | 2015-03-24 |
| A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®), Placebo - Chronic Kidney Disease, Dialysis | Phase 3 | Terminated | Tanabe Pharma Corporation | 6 | 2007-05-01 | 2011-11-15 |
Hyperphosphatemia (8) · Renal Insufficiency, Chronic (5) · Kidney Failure, Chronic (2)
Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Chronic Disease (7) · Disease Attributes (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Kidney Diseases (7) · Male Urogenital Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Renal Insufficiency (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Renal Insufficiency, Chronic (2)
cholebine (3) · Sevelamer (2) · iron-magnesium hydroxycarbonate (2) · calcium acetate (1) · lanthanum carbonate (1) · sucroferric oxyhydroxide (1)
Tanabe Pharma Corporation (4) · Ineos Healthcare Limited (2) · Genzyme, a Sanofi Company (1) · Vifor Fresenius Medical Care Renal Pharma (1)
United Kingdom (5) · France (4) · Germany (4) · Italy (3) · Poland (3) · South Africa (3) · Spain (3) · United States (3) · Brazil (2) · Czechia (2) · Hungary (2) · Lithuania (2) · Serbia (2) · Australia (1) · Austria (1)
Larry A Greenbaum, MD; PhD (1)
2008 (2)